Published on 10 May 2024 on Zacks via Yahoo Finance
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
Dr. Reddy's Laboratories Limited RDY reported fourth-quarter fiscal 2024 earnings of 94 cents per American Depositary Share (ADS), which beat the Zacks Consensus Estimate of 86 cents per ADS. In the year-ago quarter, the company reported earnings of 69 cents per ADS.
Revenues grew 12% year over year to $850 million, surpassing the Zacks Consensus Estimate of $825 million. The year-over-year improvement was primarily driven by growth in global generics revenues in North America as well as Emerging Markets.